Back
Bicycle Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
17
BCYC
Bicycle Therapeutics PLC
Last Price:
23.50
Seasonality Move:
18.56%
Sell
29
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.83
Seasonality Move:
40.93%
Sell
17
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC a Buy, Sell or Hold?
- The current Bicycle Therapeutics PLC [BCYC] share price is $23.46. The Score for BCYC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- BCYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.81. The Score for ADAP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCYC Stock Price Chart
What is Bicycle Therapeutics PLC's stock price today?
-
The Bicycle Therapeutics PLC share price today is $23.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCYC is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.81
The current trend is relatively stagnant and ADAP is experiencing slight selling pressure.
BCYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 42.03 | Sell |
| Chaikin Money Flow: | -21609 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.02 - 26.18) | Sell |
| Bollinger Bands (100): | (21.28 - 25.22) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 46 | Sell |
| Chaikin Money Flow: | -79077 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.77 - 0.91) | Sell |
| Bollinger Bands (100): | (0.87 - 1.21) | Sell |
BCYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.05 | Sell |
| 20-day SMA: | 25.07 | Sell |
| 50-day SMA: | 24.13 | Sell |
| 200-day SMA: | 22.85 | Buy |
| 8-day EMA: | 24.01 | Sell |
| 20-day EMA: | 24.5 | Sell |
| 50-day EMA: | 24.21 | Sell |
| 200-day EMA: | 22.9 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Buy |
| 20-day SMA: | 0.82 | Sell |
| 50-day SMA: | 0.97 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.77 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.92 | Sell |
| 200-day EMA: | 1.04 | Sell |
Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and a decrease next year of $0.44 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Bicycle Therapeutics PLC Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||